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To the editor, I n his recent column, Dr. Michael Lee makes an excellent point concerning the nature of compliance among patients for spine surgery [6] . Comorbidities such as poorly controlled diabetes and lifestyle choices like smoking and obesity have profound impacts on outcomes in a wide variety of surgical settings. Particularly for spine surgery, in which proper patient selection is crucial to establishing good outcomes, surgeons need to pay attention to the impact they can have on noncompliant patients. Dr. Lee correctly writes of withholding surgical interventions until a patient can demonstrate compliance with diet, exercise, smoking cessation, and glycemic control.
Offering treatment without screening a population for good prognostic factors is wasteful; denying good candidates an intervention while offering it to poor candidates creates a two-tier system in which patients with poorer prognoses get the most care while those with treatable disease are denied necessary interventions. Surgeons may not think of themselves as denying treatment to a patient, but consuming scarce operating room time on candidates with poor prognostic factors denies treatment to better candidates. The benefits of making better choices are three-fold: (1) Surgeons improve their overall outcomes, and thus their satisfaction;
(2) individual patients experience an extended increase in quality adjusted life years, and (3) society benefits as resources are distributed to those who can most effectively contribute back.
Healthcare resources are a finite commodity, and should be applied to the most appropriate candidates. Berven et al. [2] reported on the importance of instituting a pay-for-performance program for spine therapies and Glassman et al. [4] found that spinal fusion procedures could be cost-effective, particularly when applied to younger, employed individuals with fewer comorbidities. Proper glycemic control, weight loss, and smoking cessation have positive impacts on outcomes, lower the cost associated with procedures, decrease the cost-to-benefit ratio associated with intervention, and provide a higher quality of life for patients [5, 7, 8] .
The Centers for Medicare & Medicaid Services (CMS) has a uniquely positioned carrot in the healthcare marketplace. Dr. Lee's recommendation of a minimum requirement of patient compliance in order to qualify for surgical treatment is a step in the right direction. Since Medicare and Medicaid set the bar in terms of reimbursement, it is in CMS's best interest to assure that patient selection criteria are applied across the board. CMS accounts for an outsize portion of healthcare expenditures [1] . With healthcare expenditure reaching USD 2.8 trillion in 2012 (17.2% of the US gross domestic product) [3] , determining the best value for payment is critical. As the single most important payor in the heathcare system -and with the imprimatur provided by the Patient Protection and Affordable Care Act -CMS is poised to aid physicians by altering the equation of diagnosis and treatment through specific economic incentives.
If surgeons do not regulate themselves and consider their patient selection more carefully, CMS will do it for them.
